We are commissioned to co-write proposals to secure major research funding for leading consortia who want to bring hard science, clinical practice and patient advocacy together in improving patient outcomes in cancer care. In the last 4 years we have worked with NKI, IOV-IRCCS, NUST and OECI to secure over €27 million in funding for 5 projects (PRECISION, B-CAST, INTENT, COLOSYS and BenchCan). Beyond this we have brought our experience and knowledge together as an advisor (WHO EURO, DG REGIO) or external evaluator for programmes (H2020, EU Health Programme) and projects (RegHealth-RI).
While HCN started in 2005 as an INTERREG IIIC funded network operation, since 2008, HCN (registered as a non-profit company) has worked to help close the gap between what we know and what we need to do by generating practical "how-to" knowledge in all our streams of work. This is shaped by 5 guiding principles to create value over time: connectivity, pluralism, innovation, resilience and added value. To achieve this, we have worked with people at all levels from government minister to community groups, from comprehensive cancer centres to SME owners and from senior decision makers to students.
HCN also has a network of colleagues across the EU that we involve as in-house consultants when needed.